Cardiomyopathy Panel
ATTENTION: This test is being retired. The last day to order this test is August 26, 2024. Samples must be received by September 9, 2024, or your order will be canceled.
New York
Approved
Genes
Conditions
- Dilated Cardiomyopathy (DCM)
- Hypertrophic Cardiomyopathy (HCM)
- Left Ventricular Noncompaction (LVNC)
- Noonan Syndrome
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Clinical Utility
- Molecular confirmation of a clinical diagnosis in symptomatic patients
- Risk assessment of asymptomatic family members of a proband with cardiomyopathy
- Differentiation of hereditary cardiomyopathy from acquired (non-genetic) cardiomyopathy
- Recurrence risk calculation
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
694
CPT Codes*
81439x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
For Providers
Targeted Variant Testing